New Information About COVID19 and Taking Lemtrada

Lemtrada Stroke Lawsuit News

New information is available every day as scientists study the effects of disease-modifying therapies (DMTs) like Lemtrada on the immune system

Thursday, July 16, 2020 - Relapse-remitting multiple sclerosis patients (RRMS) are concerned that they may be more susceptible to contracting the virus and that the symptoms of the virus could be life-threatening after having taken Lemtrada. A study concluded the other day, however, offered hope that just the opposite may be true... that taking Lemtrada may make the Coronovirus's symptoms less severe. According to Managed Healthcare (MHE), "Patients with multiple sclerosis (MS) who are taking alemtuzumab (Lemtrada) may have milder symptoms when infected with coronavirus disease 2019 (COVID-19), according to a small study of 10 patients with relapsing-remitting MS. The study offers new data on what is a complicated question for physicians: How to best treat patients with MS given concerns that some disease-modifying therapies (DMTs) might render patients more susceptible to COVID-19."

While this study is encouraging, RRMS physicians continue to advise their patients who are looking to start Lemtrada treatments to continue with their plans and to exercise more caution than other individuals. According to MHE, Kathleen Costello, MS, ANP-BC, MSCN, associate vice president for healthcare access at the National Multiple Sclerosis Society, expressed her thought on what she would be advising patients on DMTs. "Those people on certain DMT's that deplete immune system cells should be vigilant with precautions to reduce the spread of the virus, such as wearing a mask in public, frequent and thorough hand washing, social distancing, and avoiding crowds or large gatherings." If you or a loved one have suffered the adverse health consequences of Lemtrada and have not been advised beforehand that such were possible, Lemtrada stroke lawsuit attorneys are offering a free no-obligation, consultation before filing a lawsuit.

Other doctors expressed more concern and urged patients to postpone DMTs that were known to weaken the immune system. Jordi Matias-Guiu, M.D., Ph.D published a recent paper in the Journal Multiple Sclerosis and Related Disorders, advising patients to, "temporarily delay(ing) treatment with immunosuppressive DMTs, particularly if the DMT in question was associated with depletion of lymphocytes. The fear was that such patients would be left more vulnerable to COVID-19." The doctor concluded "Obviously, more studies will come out, but in any case, it does not seem that there should be an additional fear [about MS patients taking DMTs] to that of the rest of the population," MHE reported.

Lemtrada is a serious medication that carries life-threatening complications such as causing sudden death. Doctors have reported that Lemtrada patients have died from having a stroke or heart attack within 24 hours of receiving a Lemtrada infusion. Lemtrada is classified as a disease-modifying therapy (DMT) and should be taken as a last resort only when all other potential DMTs have been attempted and failed according to medical health experts in the field. Most recently, Lemtrada is suspecting of causing ANCA vasculitis (anti-neutrophil cytoplasmic autoantibody), Anca vasculitis is an autoimmune disease that causes blood vessels to swell and causing white blood cell to attack neutrophil blood cells that break through the blood vessel walls trying to escape.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.